CD200 restrains macrophage attack on oligodendrocyte precursors via toll-like receptor 4 downregulation

Kazuhide Hayakawa1, Loc-Duyen D Pham2, Ji Hae Seo3

  • 1Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, USA Khayakawa1@mgh.harvard.edu Lo@helix.mgh.harvard.edu.

Insights

Inflammatory macrophages damage white matter repair by attacking oligodendrocyte precursor cells. Inhibiting this attack with CD200-Fc promotes myelin repair after central nervous system injury.

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • White matter repair after central nervous system (CNS) injury is hindered by poorly understood mechanisms.
  • Oligodendrocyte precursor cells (OPCs) are crucial for endogenous myelin repair.
  • Inflammatory macrophages are implicated in CNS damage but their role in OPCs' fate is unclear.

Purpose of the Study:

  • To investigate the hypothesis that inflammatory macrophages attack OPCs via toll-like receptor 4 (TLR4) signaling, impairing white matter repair.
  • To explore the therapeutic potential of targeting this pathway for promoting CNS repair.

Main Methods:

  • Primary cell cultures of peritoneal macrophages and OPCs were used to study cell interactions.
  • In vitro experiments assessed OPC phagocytosis by macrophages and the effect of CD200-Fc.
  • An in vivo model of white matter ischemia induced by endothelin-1 was employed to test CD200-Fc treatment.

Main Results:

  • Peritoneal macrophages were shown to attack and digest OPCs through TLR4 signaling in vitro.
  • CD200-Fc treatment inhibited this macrophage-mediated OPC phagocytosis by downregulating TLR4.
  • In vivo, CD200-Fc treatment reduced TLR4 expression in circulating macrophages, decreased OPC phagocytosis, and improved myelination following ischemic white matter injury.

Conclusions:

  • Inflammatory macrophages can attack OPCs via TLR4 signaling, representing a significant barrier to endogenous white matter repair after CNS injury.
  • Targeting the TLR4 pathway with CD200-Fc offers a promising therapeutic strategy to enhance OPC-mediated myelin repair in the mammalian brain.